September 11, 2020 Chromatography Environ, Ag./Food & Bev Lab Top-10 Liq. Handling & Robotics M&A, Partnerships

Bruker Announces Acquisition of Canopy Biosciences, LLC

Strengthens Bruker in Targeted Multi-Omics and High-Plex Biomarker Imaging Adds Innovative ChipCytometry Tools for Multi-Dimensional Immune Profiling BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based... Read more

April 29, 2019 Cell Analysis Tools M&A, Partnerships

Canopy Biosciences Acquires Zellkraftwerk GmbH

 April 29, 2019 Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis Products and Services ST. LOUIS — Canopy BiosciencesTM, LLC, a leading provider of gene editing and gene expression products and services, announced today that it has acquired Zellkraftwerk GmbH, a leader in... Read more

March 29, 2019 Life Science Tools Product Launch

Canopy Biosciences Launches New Technology Vastly Improving Sensitivity of Next Generation Sequencing

ST. LOUIS, March 29, 2019 — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today the launch of RareSeq, a new error corrected sequencing service that vastly increases the sensitivity of genetic testing over traditional methods. This technology, exclusively licensed from Washington University and developed by Todd... Read more

March 5, 2019 Licensing, IP, and Legal Life Science Tools

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

M ST. LOUIS, March 5, 2019 /PRNewswire/ — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation sequencing (NGS) from Washington University.  This license includes both a novel method and bioinformatic tools that combine to significantly improve... Read more

October 9, 2018 Product Launch

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

October 9, 2018 Canopy brings CRISPR technology within the reach of millions of researchers worldwide. Canopy BiosciencesTM, LLC, an established provider of gene editing and personalized medicine technologies, today announced the introduction of a new catalog of over 2000 knockout cell lines and cell lysates. The cell line catalog has been generated using CRISPR-Cas9 technology... Read more

May 22, 2018 Life Science Tools PR/Corporate

Biogenerator and Kingdom Capital Lead $2.4 Million Series a Venture Capital Financing for Canopy Biosciences

May 22, 2018 Startup to Advance Research Tools Development and Add Jobs  ST. LOUIS – Canopy Biosciences has exceeded its Series A financing goal, closing a $2.4 million investment to develop new research tools, commercialize its cutting-edge products, and hire additional employees. BioGenerator, the investment arm of BioSTL, and Kingdom Capital co-led the multi-million-dollar deal. ... Read more

November 13, 2017 Life Science Tools Product Launch

Canopy Biosciences Launches CRISPR Complete Gene Editing Kits

ST. LOUIS, Nov. 13, 2017 /PRNewswire/ — Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene editing with the CRISPR-Cas9 system.... Read more

November 13, 2017 Life Science Tools Product Launch

New CRISPR Kits Simplify Gene Editing

Canopy Biosciences launches CRISPR Complete Gene Editing Kits ST. LOUIS, Nov. 13, 2017 /PRNewswire/ — Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene... Read more

July 14, 2017 Bio/Pharma/CRO M&A, Partnerships

Canopy Biosciences Enters Bioprocessing Market with Launch of Host Cell Protein Detection Kits

Canopy Biosciences signs deal with Array Bridge to market kits for impurity analysis ST. LOUIS, July 13, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of gene editing and personalized medicine technologies, announced today that it will enter the bioprocessing field by marketing kits for host cell protein detection. Array Bridge, a biotech company that developed the... Read more

June 22, 2017 Life Science Tools M&A, Partnerships

Canopy Biosciences Announces Distribution Agreement with Cosmo Bio for Japan Life Science Market

Canopy Biosciences signs agreement with Cosmo Bio to sell gene engineering products in Japan ST. LOUIS, June 22, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio“) for its TUNR Flexible Gene Editing technology in Japan. ... Read more